X
ACHEMA MIDDLE EAST
Pharma Advancement
DDF Summit
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Drug Manufacturing

    GSK to Invest $30B in Drug Manufacturing and R&D in the US

    Sodium Oxybate Oral Solution

    Amneal Secures FDA Approval for Sodium Oxybate Oral Solution

    Bladder Cancer Treatment

    US FDA Approves Bladder Cancer Treatment Inlexzo from J&J

    Lilly TuneLab

    Eli Lilly Unveils Lilly TuneLab for AI-driven Drug Discovery

    Sensor Technology

    Enhancing Clinical Research with Advanced Sensor Technology

    Recombinant VWF

    FDA Approves Recombinant VWF Treatment in Pediatric Patients

    Novartis and Argo

    Novartis and Argo Signs Deal of up to $5.2b for Heart Drugs

    Novartis and Arrowhead

    Novartis and Arrowhead Sign Deal to Advance Parkinson’s Drug

    Eisais Leqembi IQLIK

    FDA Approves Eisai’s Leqembi IQLIK for Alzheimer’s Treatment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Drug Manufacturing

    GSK to Invest $30B in Drug Manufacturing and R&D in the US

    Sodium Oxybate Oral Solution

    Amneal Secures FDA Approval for Sodium Oxybate Oral Solution

    Bladder Cancer Treatment

    US FDA Approves Bladder Cancer Treatment Inlexzo from J&J

    Lilly TuneLab

    Eli Lilly Unveils Lilly TuneLab for AI-driven Drug Discovery

    Sensor Technology

    Enhancing Clinical Research with Advanced Sensor Technology

    Recombinant VWF

    FDA Approves Recombinant VWF Treatment in Pediatric Patients

    Novartis and Argo

    Novartis and Argo Signs Deal of up to $5.2b for Heart Drugs

    Novartis and Arrowhead

    Novartis and Arrowhead Sign Deal to Advance Parkinson’s Drug

    Eisais Leqembi IQLIK

    FDA Approves Eisai’s Leqembi IQLIK for Alzheimer’s Treatment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

Royal DSM Completes Acquisition of Specialty Dairy Solutions Provider CSK

Content Team by Content Team
7th January 2020
in Health & Nutrition, News
Royal DSM Completes Acquisition of Specialty Dairy Solutions Provider CSK

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The collaboration between Royal DSM and CSK will enable DSM to cater to the growing dairy markets around the globe. The deal was closed for a cash consideration of about 167 million dollars.

Heerlen/The Netherlands – Royal DSM, a global science-based company in nutrition, health and sustainable living, has recently announced the completion of the acquisition of a 100 % interest in specialty dairy solutions provider Koninklijke CSK Food Enrichment (CSK) for a cash consideration of about 167 million dollars. The acquisition of CSK was first announced on November 18.

The highly complementary combination of DSM’s dairy business and CSK’s business greatly strengthens DSM’s ability to serve the needs of dairy industries worldwide, and makes the company well-placed to address the fast-growing and attractive dairy cultures markets.

Previous Post

Cergentis launches TLA technology for complete cancer gene mutation sequencing

Next Post

Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

Related Posts

Drug Manufacturing
Americas

GSK to Invest $30B in Drug Manufacturing and R&D in the US

18th September 2025
Sodium Oxybate Oral Solution
Drug Development

Amneal Secures FDA Approval for Sodium Oxybate Oral Solution

17th September 2025
misleading drug advertising
Facilities & Operation

US FDA Tightens Oversight on Misleading Drug Advertising

16th September 2025
Bladder Cancer Treatment
Drug Development

US FDA Approves Bladder Cancer Treatment Inlexzo from J&J

13th September 2025
Lilly TuneLab
Drug Development

Eli Lilly Unveils Lilly TuneLab for AI-driven Drug Discovery

12th September 2025
Recombinant VWF
Drug Development

FDA Approves Recombinant VWF Treatment in Pediatric Patients

9th September 2025
Next Post
Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In